Marquette Presents: Schizophrenia forum addresses treatment through drug development
The College of Health Sciences continued the success of its popular Marquette Presents series with a forum on schizophrenia, titled Schizophrenia – New Hope for Effective Treatment Through Drug Development. The forum was held at the Alumni Memorial Union on May 31st, and attended by an audience of 200.
The expert panel, moderated by Dr. William Cullinan, dean of the College of Health Sciences, included:
- Dr. David Baker, professor and associate chair of biomedical sciences and co-founder of Promentis Pharmaceuticals Inc., a start-up company dedicated to discovering new treatments for neuropsychiatric diseases including schizophrenia.
- Dr. M. Behnam Ghasemzadeh, associate professor of biomedical sciences and co-founder of AviMed Pharmaceuticals, a start-up company focused on generation of CNS pharmaceuticals through drug repurposing, with a focus on schizophrenia.
- Dr. Jerry Halverson, medical director of Adult Services at Rogers Memorial Hospital and a board-certified adult psychiatrist.
- Ben Fendrick, a young man currently living with and coping with schizophrenia.
The full video of the forum and panel presentation is available on the College of Health Sciences’ web page.